Cargando…
mTOR inhibition: a double-edged sword in patients with COVID-19?
The current COVID-19 is one of the deadliest pandemics in recent decades. In the lack of a specific treatment for this novel infection, knowing the role of cell signaling pathways in the pathogenesis of this infection could be useful in finding effective drugs against this disease. The mammalian or...
Autor principal: | Ghasemnejad-Berenji, Morteza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849963/ https://www.ncbi.nlm.nih.gov/pubmed/33527306 http://dx.doi.org/10.1007/s13577-021-00495-2 |
Ejemplares similares
-
Second Generation mTOR Inhibitors as a Double-Edged Sword in Malignant Glioma Treatment
por: Heinzen, Dennis, et al.
Publicado: (2019) -
MAVS is a double-edged sword
por: Huang, Christina, et al.
Publicado: (2023) -
A double-edged sword of using opioids and COVID-19: a toxicological view
por: Ataei, Mahshid, et al.
Publicado: (2020) -
Interactions of Viruses with Dendritic Cells: A Double-edged Sword
por: Bhardwaj, Nina
Publicado: (1997) -
Antiplatelet therapy: a double-edged sword in head injury?
por: Beynon, Christopher, et al.
Publicado: (2013)